1. Anti-infection Cell Cycle/DNA Damage Immunology/Inflammation Apoptosis
  2. Bacterial Antibiotic DNA/RNA Synthesis Interleukin Related Apoptosis
  3. Clofazimine

Clofazimine  (Synonyms: クロファジミン)

製品番号: HY-B1046 純度: 99.79%
COA 取扱説明書 Technical Support

Clofazimine is an orally-active anti-mycobacterial agent with a wide range of anti-mycobacterial activity including leprosy and tuberculosis. Clofazimine exerts anti-inflammatory activities and anti-tumor activities by interfering DNA replication and inhibiting IL2 (IC50 = 1.10 ± 0.26 μM, Jurkat T) production. Clofazimine can be used in mycobacterial and cancer research.

商品は「研究用試薬」です。人や動物の医療用・臨床診断用・食品用の製品ではありません。
研究用途以外に使用した場合、当社は一切の責任を負いかねます。

CAS 番号 : 2030-63-9

容量 価格(税別) 在庫状況 数量
Solid + Solvent (Highly Recommended)
10 mM * 1 mL in DMSO
ready for reconstitution
USD 41 在庫あり
Solution
10 mM * 1 mL in DMSO USD 41 在庫あり
Solid
500 mg $38 在庫あり
1 g $60 在庫あり
5 g $170 在庫あり
10 g $286 在庫あり
50 g   お問い合わせ  

* アイテムを追加する前、数量をご選択ください

This product is a controlled substance and not for sale in your territory.

カスタマーレビュー

Based on 12 publication(s) in Google Scholar

Other Forms of Clofazimine:

Top Publications Citing Use of Products

    Clofazimine purchased from MedChemExpress. Usage Cited in: Sci Adv. 2025 Mar 21;11(12):eads9182.  [Abstract]

    Clofazimine (15 μM; 24 h) significantly blocked OA-induced expression of H3K4me3-controlled genes AGR2 and PARM1, with a trend toward reduced PHGDH and NTRK2 expression in microstructures from BRCA1 wild-type individuals.

    Clofazimine purchased from MedChemExpress. Usage Cited in: Commun Biol. 2025 Oct 6;8(1):1425.  [Abstract]

    Clofazimine (CFZ) (3.125 μg/mL; 48 h) markedly reduced the survival of ΔcysE Mycobacterium tuberculosis H37Rv.

    Clofazimine purchased from MedChemExpress. Usage Cited in: Commun Biol. 2025 Oct 6;8(1):1425.  [Abstract]

    Clofazimine (CFZ) (15.625-31.25 μg/mL; 1-3 h) strongly increased ROS levels in M. tb (Mycobacterium tuberculosis).

    Clofazimine purchased from MedChemExpress. Usage Cited in: Commun Biol. 2025 Oct 6;8(1):1425.  [Abstract]

    Early-log-phase cultures of WT and ΔcysE M. tb (Mycobacterium tuberculosis) were treated with or without Clofazimine (CFZ) (3.125–6.25 μg/mL; 7 d). Survival was determined in the form of viable bacterial count expressed as CFU.

    Clofazimine purchased from MedChemExpress. Usage Cited in: Patent. US20250312336A1.

    The weights of orthotopic syngeneic pancreatic tumors from C57BL/6J mice followed treatment with ANO6 inhibitors Clofazimine (50 mg/kg; p.o.; 3 weeks).

    Clofazimine purchased from MedChemExpress. Usage Cited in: Cell Death Discov. 2022 Mar 12;8(1):111.  [Abstract]

    Clofazimine (Verteporfin) (5 μM) reduced the expression of steogenesis related genes (RUNX2, ALP, OSX) in BMSCs.
    • 生物活性

    • 純度とドキュメンテーション

    • 参考文献

    • カスタマーレビュー

    製品説明

    Clofazimine is an orally-active anti-mycobacterial agent with a wide range of anti-mycobacterial activity including leprosy and tuberculosis. Clofazimine exerts anti-inflammatory activities and anti-tumor activities by interfering DNA replication and inhibiting IL2 (IC50 = 1.10 ± 0.26 μM, Jurkat T) production. Clofazimine can be used in mycobacterial and cancer research[1][2][3][4][5].

    IC50 & Target

    Quinolone

     

    Cellular Effect
    Cell Line Type Value Description References
    BT-20 IC50
    19 μM
    Compound: Clofazimine
    Cytotoxicity against human BT-20 cells incubated for 3 to 4 days by MTT assay
    Cytotoxicity against human BT-20 cells incubated for 3 to 4 days by MTT assay
    [PMID: 34116325]
    HMEC-1 CC50
    18.6 μM
    Compound: CFM
    Cytotoxicity against human HMEC1 cells assessed as reduction in cell viability after 72 hrs by MTT method
    Cytotoxicity against human HMEC1 cells assessed as reduction in cell viability after 72 hrs by MTT method
    [PMID: 25464882]
    HMEC-1 IC50
    18.59 μM
    Compound: Clofazimine
    Cytotoxicity against HMEC1 cells after 72 hrs by MTT assay
    Cytotoxicity against HMEC1 cells after 72 hrs by MTT assay
    [PMID: 25497962]
    HepG2 CC50
    49.02 μg/mL
    Compound: CLFZ
    Cytotoxicity against human HepG2 cells assessed as reduction in cell viability by MTT assay
    Cytotoxicity against human HepG2 cells assessed as reduction in cell viability by MTT assay
    [PMID: 38784457]
    Huh-7 CC50
    44.7 μM
    Compound: 1
    Cytotoxicity against human HuH-7 cells assessed as reduction in cell viability incubated for 24 hrs by microplate reader assay
    Cytotoxicity against human HuH-7 cells assessed as reduction in cell viability incubated for 24 hrs by microplate reader assay
    [PMID: 35279610]
    MT4 CC50
    6.8 μM
    Compound: CFM
    Cytotoxicity against human MT4 cells assessed as reduction in cell viability after 96 hrs by MTT method
    Cytotoxicity against human MT4 cells assessed as reduction in cell viability after 96 hrs by MTT method
    [PMID: 25464882]
    NIH-3T3-G185 IC50
    0.6 μM
    Compound: Clofazimine
    TP_TRANSPORTER: inhibition of Daunorubicin efflux in NIH-3T3-G185 cells
    TP_TRANSPORTER: inhibition of Daunorubicin efflux in NIH-3T3-G185 cells
    [PMID: 11716514]
    NIH-3T3-G185 IC50
    1 μM
    Compound: Clofazimine
    TP_TRANSPORTER: inhibition of Rhodamine 123 efflux in NIH-3T3-G185 cells
    TP_TRANSPORTER: inhibition of Rhodamine 123 efflux in NIH-3T3-G185 cells
    [PMID: 11716514]
    NIH-3T3-G185 IC50
    1.1 μM
    Compound: Clofazimine
    TP_TRANSPORTER: inhibition of LDS-751 efflux in NIH-3T3-G185 cells
    TP_TRANSPORTER: inhibition of LDS-751 efflux in NIH-3T3-G185 cells
    [PMID: 11716514]
    Vero IC50
    68.6 μg/mL
    Compound: CFZ
    Cytotoxicity against african green monkey Vero cells after 48 hrs by MTT assay
    Cytotoxicity against african green monkey Vero cells after 48 hrs by MTT assay
    [PMID: 22931472]
    Vero 76 CC50
    > 100 μM
    Compound: CFM
    Cytotoxicity against african green monkey Vero 76 cells assessed as reduction in cell viability after 48 to 96 hrs by MTT method
    Cytotoxicity against african green monkey Vero 76 cells assessed as reduction in cell viability after 48 to 96 hrs by MTT method
    [PMID: 25464882]
    体外実験

    Clofazimine (0.0625-2 mg/L, 14 d) exerts no apparent activity against M. tuberculosis during the first 2–4 days of exposure, exhibits a concentration-dependent antimicrobial activity after 1 week: bacteriostatic activity at concentrations at or below the 0.25 mg/L MIC and bactericidal activity at concentrations above the MIC. INH is used as positive control.[3].
    Clofazimine (10 μM, 24 h) inhibits the growth of hematological cancer cell lines (Jurkat, U266, Namalwa, K562, HL60)[4].
    Clofazimine (1-50 μM, 12-48 h) shows a dose- and time-dependent inhibitory effect for U266[4].
    Clofazimine (10 μM, 24-48 h) depolarizes the mitochondrial membrane, significantly increases active caspase-3 level (25-fold) and increases the percentage of early and late apoptotic cells in U266[4].

    MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.

    体内実験

    Clofazimine (100,50 mg/kg, p.o., once per day for 14 d) exhibits a delayed antimicrobial activity against Mycobacterium tuberculosis in mice[3].

    MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.

    Animal Model: Female BALB/c mice (age 6–8 weeks, mass 18–20 g)[3]
    Dosage: 100, 50, 25, 12.5, 6.25, 3.125 or 1.5625 mg/kg
    Administration: Oral gavage (p.o.), once per day for 14 d
    Result: Exhibited an increase of the lung bacterial load during the first 7 days of treatment, and decreased the CFU counts in the lungs of mice after 10 days of treatment.
    Significantly declined the lung CFU counts in 100 or 50 mg/ kg group at 14th day.
    臨床実験
    分子量

    473.40

    分子式

    C27H22Cl2N4

    CAS 番号
    Appearance

    Solid

    Color

    Pink to red

    SMILES

    CC(/N=C1C(NC2=CC=C(Cl)C=C2)=CC3=NC4=C(C=CC=C4)N(C5=CC=C(Cl)C=C5)C3=C/1)C

    輸送条件

    Room temperature in continental US; may vary elsewhere.

    保管条件

    4°C, protect from light

    *In solvent : -80°C, 6 months; -20°C, 1 month (protect from light)

    溶剤 & 溶解度
    体外: 

    DMSO : 6.25 mg/mL (13.20 mM; Need ultrasonic; Hygroscopic DMSO has a significant impact on the solubility of product, please use newly opened DMSO)

    H2O : < 0.1 mg/mL (insoluble)

    Preparing
    Stock Solutions
    Concentration Solvent Mass 1 mg 5 mg 10 mg
    1 mM 2.1124 mL 10.5619 mL 21.1238 mL
    5 mM 0.4225 mL 2.1124 mL 4.2248 mL
    10 mM 0.2112 mL 1.0562 mL 2.1124 mL
    View the Complete Stock Solution Preparation Table

    * Please refer to the solubility information to select the appropriate solvent. Once prepared, please aliquot and store the solution to prevent product inactivation from repeated freeze-thaw cycles.
    Storage method and period of stock solution: -80°C, 1 year; -20°C, 6 months (protect from light). When stored at -80°C, please use it within 1 year. When stored at -20°C, please use it within 6 months.

    • Molarity Calculator

    • Dilution Calculator

    Mass (g) = Concentration (mol/L) × Volume (L) × Molecular Weight (g/mol)

    Mass
    =
    Concentration
    ×
    Volume
    ×
    Molecular Weight *

    Concentration (start) × Volume (start) = Concentration (final) × Volume (final)

    一般には略語で表示されます:C1V1 = C2V2

    濃度 (開始)

    C1

    ×
    体積 (開始)

    V1

    =
    濃度 (終了)

    C2

    ×
    体積 (終了)

    V2

    In Vivo Dissolution Calculator
    Please enter the basic information of animal experiments:

    Dosage

    mg/kg

    Animal weight
    (per animal)

    g

    Dosing volume
    (per animal)

    μL

    Number of animals

    Recommended: Prepare an additional quantity of animals to account for potential losses during experiments.
    Calculation results:
    Working solution concentration: mg/mL
    純度とドキュメンテーション

    純度: 99.79%

    参考文献

    Complete Stock Solution Preparation Table

    * Please refer to the solubility information to select the appropriate solvent. Once prepared, please aliquot and store the solution to prevent product inactivation from repeated freeze-thaw cycles.
    Storage method and period of stock solution: -80°C, 1 year; -20°C, 6 months (protect from light). When stored at -80°C, please use it within 1 year. When stored at -20°C, please use it within 6 months.

    Optional Solvent Concentration Solvent Mass 1 mg 5 mg 10 mg 25 mg
    DMSO 1 mM 2.1124 mL 10.5619 mL 21.1238 mL 52.8095 mL
    5 mM 0.4225 mL 2.1124 mL 4.2248 mL 10.5619 mL
    10 mM 0.2112 mL 1.0562 mL 2.1124 mL 5.2809 mL
    • No file chosen (Maximum size is: 1024 Kb)
    • If you have published this work, please enter the PubMed ID.
    • Your name will appear on the site.
    • Molarity Calculator

    • Dilution Calculator

    The molarity calculator equation

    Mass (g) = Concentration (mol/L) × Volume (L) × Molecular Weight (g/mol)

    質量   濃度   体積   分子量 *
    = × ×

    The dilution calculator equation

    Concentration (start) × Volume (start) = Concentration (final) × Volume (final)

    一般には略語で表示されます:C1V1 = C2V2

    濃度 (開始) × 体積 (開始) = 濃度 (終了) × 体積 (終了)
    × = ×
    C1   V1   C2   V2
    Help & FAQs
    • Do most proteins show cross-species activity?

      Species cross-reactivity must be investigated individually for each product. Many human cytokines will produce a nice response in mouse cell lines, and many mouse proteins will show activity on human cells. Other proteins may have a lower specific activity when used in the opposite species.

    最近チェックした製品:

    オンラインお問い合わせ

    Your information is safe with us. * Required Fields.

    製品名

     

    カスタマ需要量 *

    お名前 *

     

    タイトル

    メールアドレス *

     

    電話番号 *

    デパートメント

     

    組纖名 *

    市区町村

    都道府県

    国或いは地域 *

         

    必ず会社名を記載ください。個人への返信は行いません。

    備考

    バルクお問い合わせ

    Inquiry Information

    製品名:
    Clofazimine
    製品番号:
    HY-B1046
    数量:
    MCE 日本正規代理店: